Cite

HARVARD Citation

    Hatch, R. et al. (2022). Day 4 vs. day 12 G-CSF administration following reduced intensity peripheral blood allogeneic stem cell transplant. Journal of oncology pharmacy practice. pp. 892-897. [Online]. 
  
Back to record